337 related articles for article (PubMed ID: 28095111)
1. Increased Numb protein expression predicts poor clinical outcomes in esophageal squamous cell carcinoma patients.
Liu Z; Luo C; Yang W; Wang K; Hu C; Zou J; Zhu H; Fu L; Nie J; Cheng C
Cancer Biol Ther; 2018 Jan; 19(1):34-41. PubMed ID: 28095111
[TBL] [Abstract][Full Text] [Related]
2. High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
Feng Y; Yan S; Huang Y; Huang Q; Wang F; Lei Y
BMC Cancer; 2020 Jun; 20(1):602. PubMed ID: 32600359
[TBL] [Abstract][Full Text] [Related]
3. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma.
Qin G; Lian J; Yue D; Chen X; Nan S; Qi Y; Li B; Cui G; Li X; Zhao S; Zhang Y
Oncol Rep; 2017 Sep; 38(3):1724-1732. PubMed ID: 28713964
[TBL] [Abstract][Full Text] [Related]
4. The tumor suppressive role of NUMB isoform 1 in esophageal squamous cell carcinoma.
Hong J; Liu Z; Zhu H; Zhang X; Liang Y; Yao S; Wang F; Xie X; Zhang B; Tan T; Fu L; Nie J; Cheng C
Oncotarget; 2014 Jul; 5(14):5602-14. PubMed ID: 24980814
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway.
Zhang Y; Chen W; Wang H; Pan T; Zhang Y; Li C
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1209-1218. PubMed ID: 31529206
[TBL] [Abstract][Full Text] [Related]
6. PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma.
Qian Z; Wei B; Zhou Y; Wang Q; Wang J; Sun Y; Gao Y; Chen X
BMC Cancer; 2019 Jun; 19(1):585. PubMed ID: 31200670
[TBL] [Abstract][Full Text] [Related]
7. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
[TBL] [Abstract][Full Text] [Related]
8. Monocarboxylate transporter 1 is an independent prognostic factor in esophageal squamous cell carcinoma.
Chen X; Chen X; Liu F; Yuan Q; Zhang K; Zhou W; Guan S; Wang Y; Mi S; Cheng Y
Oncol Rep; 2019 Apr; 41(4):2529-2539. PubMed ID: 30720131
[TBL] [Abstract][Full Text] [Related]
9. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
[TBL] [Abstract][Full Text] [Related]
10. TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Pham QT; Oue N; Sekino Y; Yamamoto Y; Shigematsu Y; Sakamoto N; Sentani K; Uraoka N; Yasui W
Oncology; 2018; 95(5):297-308. PubMed ID: 30134247
[TBL] [Abstract][Full Text] [Related]
11. Novel long noncoding RNA NMR promotes tumor progression via NSUN2 and BPTF in esophageal squamous cell carcinoma.
Li Y; Li J; Luo M; Zhou C; Shi X; Yang W; Lu Z; Chen Z; Sun N; He J
Cancer Lett; 2018 Aug; 430():57-66. PubMed ID: 29763634
[TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.
Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF
Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043
[TBL] [Abstract][Full Text] [Related]
13. SASS6 promotes proliferation of esophageal squamous carcinoma cells by inhibiting the p53 signaling pathway.
Xu Y; Zhu K; Chen J; Lin L; Huang Z; Zhang J; Chen Y
Carcinogenesis; 2021 Feb; 42(2):254-262. PubMed ID: 32671379
[TBL] [Abstract][Full Text] [Related]
14. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
[TBL] [Abstract][Full Text] [Related]
15. Low expression of BEX1 predicts poor prognosis in patients with esophageal squamous cell cancer.
Geng HT; Cheng ZW; Cao RJ; Wang ZB; Xing SZ; Guo C; Wang F; Liu CM; Chen SS; Cheng YF
Oncol Rep; 2018 Nov; 40(5):2778-2787. PubMed ID: 30132532
[TBL] [Abstract][Full Text] [Related]
16. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
[TBL] [Abstract][Full Text] [Related]
17. SOX9/miR-203a axis drives PI3K/AKT signaling to promote esophageal cancer progression.
Wang L; Zhang Z; Yu X; Li Q; Wang Q; Chang A; Huang X; Han X; Song Y; Hu J; Pang L; Hou J; Li F
Cancer Lett; 2020 Jan; 468():14-26. PubMed ID: 31600529
[TBL] [Abstract][Full Text] [Related]
18. Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression.
Xie Z; Li T; Huang B; Liu S; Zhang L; Zhang Q
Technol Cancer Res Treat; 2020; 19():1533033820928117. PubMed ID: 32441221
[TBL] [Abstract][Full Text] [Related]
19. NOX4 overexpression is a poor prognostic factor in patients undergoing curative esophagectomy for esophageal squamous cell carcinoma.
Chen YH; Lu HI; Lo CM; Hsiao CC; Li SH
Surgery; 2020 Mar; 167(3):620-627. PubMed ID: 31889545
[TBL] [Abstract][Full Text] [Related]
20. Prognostic values of STAT3 and HIF-1α in esophageal squamous cell carcinoma.
Zhao X; Tang YP; Wang CY; Wu JX; Ye F
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3351-3357. PubMed ID: 31081089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
